Prospective cohort study on patients of pancreatic cancer performed EUSFNA - Prospective cohort study on patients of pancreatic cancer performed EUSFNA

Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 1,000 人2017年2月22日

概览

阶段: 未知
干预措施: 未指定
疾病 / 适应症: 未指定
发起方: Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine
入组人数: 1000
状态: 招募中
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

The aim of this research is registry of pancreatic cancer performed EUSFNA. Therefore there is no main outcome. In each individual study, we will perform UMIN registration.

注册库

who.int

开始日期

2017年2月22日

结束日期

待定

最后更新

2年前

研究类型

Observational

性别

All

研究者

发起方

Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine

入排标准

入选标准

未提供

排除标准

未提供

结局指标

主要结局

未指定

相似试验

进行中（未招募）

不适用

Cohort Study of Pancreatic Cancer RiskFamilial Pancreatic Cancer

NCT04247503Mayo Clinic419

已完成

不适用

Observational study of pancreatic cancer patients with positive peritoneal lavage cytologypancreatic cancer

JPRN-UMIN000032477Shizuoka Cancer Center150

进行中（未招募）

不适用

A trial comparing the current standard treatment (gemcitabine) to the experimental, combined treatments of gemcitabine plus capecitabine.Resectable pancreatic or peri-ampullary cancersMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10034446Term: Periampullary carcinoma resectableSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Digestive System Diseases [C06]

EUCTR2007-004299-38-GBThe University of Liverpool1,396

进行中（未招募）

1 期

Comparing Gemcetabine and Capecitabine versus Gemcitabine monotherapy in chemotherapy for pancreatic cancerResectable pancreatic cancerMedDRA version: 21.0Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]

EUCTR2007-004299-38-DEThe University of Liverpool1,068

进行中（未招募）

1 期

European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer. - ESPAC-4Resectable pancreatic cancerMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864

EUCTR2007-004299-38-SEThe University of Liverpool1,080